Toll Free: 1-888-928-9744

Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2015

Published: Mar, 2015 | Pages: 25 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2015', provides an overview of the Paras Biopharmaceuticals Finland Oy's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Paras Biopharmaceuticals Finland Oy's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Paras Biopharmaceuticals Finland Oy including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Paras Biopharmaceuticals Finland Oy's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Paras Biopharmaceuticals Finland Oy's pipeline products

Reasons To Buy

- Evaluate Paras Biopharmaceuticals Finland Oy's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Paras Biopharmaceuticals Finland Oy in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Paras Biopharmaceuticals Finland Oy's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Paras Biopharmaceuticals Finland Oy and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Paras Biopharmaceuticals Finland Oy
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Paras Biopharmaceuticals Finland Oy and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Paras Biopharmaceuticals Finland Oy Snapshot 5
Paras Biopharmaceuticals Finland Oy Overview 5
Key Information 5
Key Facts 5
Paras Biopharmaceuticals Finland Oy - Research and Development Overview 6
Key Therapeutic Areas 6
Paras Biopharmaceuticals Finland Oy - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Paras Biopharmaceuticals Finland Oy - Pipeline Products Glance 10
Paras Biopharmaceuticals Finland Oy - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Paras Biopharmaceuticals Finland Oy - Drug Profiles 11
anakinra biosimilar 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
PB-3010 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
PB-3020 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
PB-3030 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
PB-3040 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PB-4020 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
PPB-4010 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
teriparatide biosimilar 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Paras Biopharmaceuticals Finland Oy - Pipeline Analysis 19
Paras Biopharmaceuticals Finland Oy - Pipeline Products by Target 19
Paras Biopharmaceuticals Finland Oy - Pipeline Products by Route of Administration 20
Paras Biopharmaceuticals Finland Oy - Pipeline Products by Molecule Type 21
Paras Biopharmaceuticals Finland Oy - Pipeline Products by Mechanism of Action 22
Paras Biopharmaceuticals Finland Oy - Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 24
Disclaimer 25
List of Tables
Paras Biopharmaceuticals Finland Oy, Key Information 5
Paras Biopharmaceuticals Finland Oy, Key Facts 5
Paras Biopharmaceuticals Finland Oy - Pipeline by Indication, 2015 7
Paras Biopharmaceuticals Finland Oy - Pipeline by Stage of Development, 2015 8
Paras Biopharmaceuticals Finland Oy - Monotherapy Products in Pipeline, 2015 9
Paras Biopharmaceuticals Finland Oy - Preclinical, 2015 10
Paras Biopharmaceuticals Finland Oy - Pipeline by Target, 2015 19
Paras Biopharmaceuticals Finland Oy - Pipeline by Route of Administration, 2015 20
Paras Biopharmaceuticals Finland Oy - Pipeline by Molecule Type, 2015 21
Paras Biopharmaceuticals Finland Oy - Pipeline Products by Mechanism of Action, 2015 22 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify